Literature DB >> 10888353

Detection of hantaviral antibodies among patients with hepatitis of unknown etiology in Japan.

H Kariwa1, K Yoshimatsu, K Araki, K Chayama, H Kumada, M Ogino, H Ebihara, M E Murphy, T Mizutani, I Takashima, J Arikawa.   

Abstract

Hantaviral antibodies were detected in the sera from patients with hepatic disease of unknown etiology in Japan by several different serological diagnostic methods. A total of 105 sera from diseased patients which were negative to A-G hepatitis virus infections in the Tokyo area were tested. Among them, 3 out of 73 sera from patients with chronic hepatic disease were positive to hantaviral antibody by enzyme-linked immunosorbent assay (ELISA), indirect immunofluorescent antibody assay (IFA) and Western blot analysis (WB). Neutralizing antibody titers of the 3 sera to Seoul virus (SEO) were 4 to 8 times higher than those to Hantaan virus (HTN). However, all of the 32 sera from patients with acute hepatitis were negative for hantaviral antibody. Among the 60 patients with chronic hepatitis in Hokkaido which were serologically negative to B and C hepatitis virus infection, one was positive for hantaviral antibody by ELISA and WB. In contrast, the sera from healthy adults in Japan, 550 from the Honshu and Kyushu regions, and 1,000 from the Hokkaido region, were negative for hantavirus antibody. These results show that hantaviral antibodies are more frequently detected in patients with hepatic disease than in healthy adults. However, the observation that no positive sera were detected from patients with acute hepatitis implies that hantavirus might not be directly related to hepatitis.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10888353     DOI: 10.1111/j.1348-0421.2000.tb02506.x

Source DB:  PubMed          Journal:  Microbiol Immunol        ISSN: 0385-5600            Impact factor:   1.955


  7 in total

1.  Molecular evolution of Puumala hantavirus.

Authors:  T Sironen; A Vaheri; A Plyusnin
Journal:  J Virol       Date:  2001-12       Impact factor: 5.103

2.  Nucleocapsid protein of cell culture-adapted Seoul virus strain 80-39: analysis of its encoding sequence, expression in yeast and immuno-reactivity.

Authors:  Jonas Schmidt; Burkhard Jandrig; Boris Klempa; Kumiko Yoshimatsu; Jiro Arikawa; Helga Meisel; Matthias Niedrig; Christian Pitra; Detlev H Krüger; Rainer Ulrich
Journal:  Virus Genes       Date:  2005-01       Impact factor: 2.332

Review 3.  Wild Rats, Laboratory Rats, Pet Rats: Global Seoul Hantavirus Disease Revisited.

Authors:  Jan Clement; James W LeDuc; Graham Lloyd; Jean-Marc Reynes; Lorraine McElhinney; Marc Van Ranst; Ho-Wang Lee
Journal:  Viruses       Date:  2019-07-17       Impact factor: 5.048

4.  Hantavirus infection in type I interferon receptor-deficient (A129) mice.

Authors:  Stuart D Dowall; Victoria A Graham; Marilyn Aram; Stephen Findlay-Wilson; Francisco J Salguero; Kirsty Emery; Roger Hewson
Journal:  J Gen Virol       Date:  2020-10       Impact factor: 3.891

5.  Non-hepatotropic viral hepatitis and its causative pathogens: The ongoing need for monitoring in children with severe acute hepatitis of unknown etiology.

Authors:  Ran Wang; Zhengde Xie
Journal:  Pediatr Investig       Date:  2022-08-01

6.  Genetic analysis of hantaviruses carried by Myodes and Microtus rodents in Buryatia.

Authors:  Angelina Plyusnina; Juha Laakkonen; Jukka Niemimaa; Kirill Nemirov; Galina Muruyeva; Boshikto Pohodiev; Ake Lundkvist; Antti Vaheri; Heikki Henttonen; Olli Vapalahti; Alexander Plyusnin
Journal:  Virol J       Date:  2008-01-11       Impact factor: 4.099

7.  Detection and genetic characterization of Seoul virus from commensal brown rats in France.

Authors:  Tatiana Dupinay; Kieran C Pounder; Florence Ayral; Maria-Halima Laaberki; Denise A Marston; Sandra Lacôte; Catherine Rey; Fabienne Barbet; Katja Voller; Nicolas Nazaret; Marc Artois; Philippe Marianneau; Joel Lachuer; Anthony R Fooks; Michel Pépin; Catherine Legras-Lachuer; Lorraine M McElhinney
Journal:  Virol J       Date:  2014-02-20       Impact factor: 4.099

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.